Family planning a human right

HealthPharmacy
Last updated on
Avatar photo
By Elizabeth Chong Yie-Chuen

A registered pharmacist on the path less trodden – A research assistant @ Monash University, #InclusionHealth advocate and a softie for all things cute

Shush! Family planning – a common taboo in our society. Many still tread lightly around this topic. Family planning education is important and should be made available to everyone. Due to the lack of education, it is not a surprise that unintended pregnancies are still occurring. Other areas that also contribute to this are the minimal family planning services made available, incorrect use of contraceptive methods and poverty.

In this ‘Contraception Conundrum’ interview with 1TWENTY80 Magazine, Cedric Chua, our very own Deputy Chairperson of the MPS-YPC sheds some light on the importance of contraception and debunks some of its myths. He also highlights the certain roles a pharmacist or healthcare professional can assume to better equip their customers on family planning.

“It is important because every pregnancy should be wanted, and every childbirth safe”

It’s high time we cleared the air on Family Planning! Awareness is key!

1TWENTY80 ARTICLE

Related

NDMA Found in Ranitidine

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   Recently, there has been news regarding the discovery of traces of N-Nitrosodimethylamin (NDMA) found in ranitidine medications. This was reported by the American-based Food and Drug Administration (FDA) as well as the Singaporean…

Stop Taking Nan Bao!

Last updated on

If you are one of those who consumes ‘Nan Bao’ capsules, be aware that the Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has released a statement that all sellers and distributors of this traditional supplement to stop all sales and distribution as it is against the Sale of Drugs Act 1952 and the Control of…

Topical Preparations Counselling Guide for Pharmacist is the first edition of its genre. It aims to provide information for pharmacists specifically on topical preparations available in the Ministry of Health (MOH) formulary and relevant counselling points on its usage in providing effective and accurate patient education regarding their medicines. The contents of this quick guide…

Starting from 1 January 2019, all applications for pharmacy licenses and permits will be associated with a newly imposed fee. The amendments are as follow: “I) Di bawah Peraturan 28 Peraturan-Peraturan Racun (Pindaan) 2018 iaitu :  28. (1) An Application for a licence under the Act shall be accompanied by the following fees:    …

Written by Tang Jia Wen, commitee member of MCPS 2.5   On 27 July 2019, the Malaysian Clinical Pharmacy Symposium (MCPS) 2.5 – A Cancer Therapy Counselling Workshop was held in International Medical University (IMU). It had successfully gathered pharmacists from different backgrounds and provided a conducive platform for them to exchange ideas and thoughts…

Stable Coronary Artery Disease (2nd Edition)

Last updated on
The previous clinical practice guidelines for the management of stable angina were issued in 2010. Since then, there have been advances in both diagnostic and therapeutic strategies in the management of this progressive disease. Therefore, it is timely for the publication of this CPG, with a title that is now evolved from stable angina to...

Others

Haze, Don’t Play Play with API

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   No, we did not upload the wrong photo. That, my friend, would be your vision if the haze continues to worsen. I’m sure many of you would be coughing or sneezing as you…

For the past week, the public (and that includes health care professionals) has been dumbfounded by the sheer impact of the toxic dump which happened along Sungai Kim Kim in Pasir Gudang, Johor. The incident, believed to have happened on 7 March has led to a plethora of health issues concerning the residents in the…

Remdesivir in Malaysia As everyone eagerly awaits results from clinical trials regarding treatment and vaccination option(s) for COVID-19, a possible “knight in shining armour” emerges: Remdesivir. Remde-saviour? Currently, the medication is undergoing 6 separate clinical trials for COVID-19: 2 initiated by Gilead (the manufacturer) (moderate & severe manifestations) 2 by health authorities in China (mild/moderate...

Poison Found in Cosmetic Product

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   This is not an april fool’s joke! The Desk of the Director General of Health released a statement on 1 April on 2 cosmetic products found to contain a scheduled poison. The 2…

[UPDATE] As of 8/12/2020 The Light at the End of the Tunnel On 8 December, the United Kingdom has been the very first nation to begin vaccinating its citizens. 90 year-old Margaret Keenan was the first Briton to receive the Pfizer/BioNTech vaccine. The UK has also placed an order for the Moderna vaccines for a...

WHO to look into drug pricing?

Last updated on

Our health ministry has urged the World Health Organisation (WHO) to look into drug pricing by major drug companies. This came about amidst the pressure on the ministry to utilise Compulsory Licensing (CL)* to gain access to generic versions of a Hepatitis C medication. “I hope the international community could look at how pharmaceutical companies…